Risk of hypoglycemia in Japanese people with type 2 diabetes mellitus who initiated or switched to insulin glargine 300 U/mL: A subgroup analysis of 12-month post-marketing surveillance study (X-STAR study).

MLA

Hirose, Takahisa, et al. “Risk of Hypoglycemia in Japanese People with Type 2 Diabetes Mellitus Who Initiated or Switched to Insulin Glargine 300 U/ML: A Subgroup Analysis of 12-Month Post-Marketing Surveillance Study (X-STAR Study).” Diabetes Research & Clinical Practice, vol. 172, Feb. 2021, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.diabres.2020.108647.

APA

Hirose, T., Odawara, M., Matsuhisa, M., Koshida, R., Senda, M., Tanaka, Y., & Terauchi, Y. (2021). Risk of hypoglycemia in Japanese people with type 2 diabetes mellitus who initiated or switched to insulin glargine 300 U/mL: A subgroup analysis of 12-month post-marketing surveillance study (X-STAR study). Diabetes Research & Clinical Practice, 172, N.PAG. https://doi.org/10.1016/j.diabres.2020.108647

Chicago

Hirose, Takahisa, Masato Odawara, Munehide Matsuhisa, Ryusuke Koshida, Masayuki Senda, Yasushi Tanaka, and Yasuo Terauchi. 2021. “Risk of Hypoglycemia in Japanese People with Type 2 Diabetes Mellitus Who Initiated or Switched to Insulin Glargine 300 U/ML: A Subgroup Analysis of 12-Month Post-Marketing Surveillance Study (X-STAR Study).” Diabetes Research & Clinical Practice 172 (February): N.PAG. doi:10.1016/j.diabres.2020.108647.